Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 2 July 2002
Vol. 2002, Issue 139, p. tw238
[DOI: 10.1126/stke.2002.139.tw238]


Cancer Biology RasGAP in the Balance

Ras GTPase-activating proteins (RasGAPs) are best known as negative regulators because they stimulate the hydrolysis of GTP by Ras. However, in cancer cells that express an oncogenic form of Ras, RasGAP can no longer deactivate Ras. Instead, it acts as a Ras effector, promoting cell proliferation. Gigoux et al. report that an interaction between the Src homology 3 (SH3) domain of RasGAP and the kinase domain of the serine-threonine kinase Aurora may account for this effect. The interaction may directly or indirectly regulate Aurora activity, which is required for mitosis. The antiapoptotic protein Survivin was also detected in a complex with Aurora and RasGAP. The authors propose that the ternary complex may regulate both cell division and apoptosis in tumor cells.

V. Gigoux, S. L'Hoste, F. Raynaud, J. Camonis, C. Garbay, Identification of Aurora kinases as RasGAP Src homology 3 domain-binding proteins. J Biol. Chem. 277, 23742-23746 (2002). [Abstract] [Full Text]

Citation: RasGAP in the Balance. Sci. STKE 2002, tw238 (2002).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882